It is well known that biallelic pathogenic variants in the PALB2 gene result in a subtype of Fanconi anemia, whereas the monoallelic pathogenic variant in PALB2 predisposes carriers to different cancers such as breast, pancreatic, and ovarian cancers (38). Here, PALB2 is linked to ovarian cancer.